Search results
Results from the WOW.Com Content Network
Chlorpromazine (CPZ), marketed under the brand names Thorazine and Largactil among others, is an antipsychotic medication. [6] It is primarily used to treat psychotic disorders such as schizophrenia . [ 6 ]
ECG changes [Note 4]; Contact dermatitis; Sensitivity to light; Urticaria (hives); Maculopapular rash; Petechia or edema; Hyperprolactinaemia [Note 5]; Impaired thermoregulation [Note 6] ...
Simone Courvoisier was a French experimental pharmacologist who, while the head of pharmacology at Rhône-Poulenc in the 1950s, investigated the use of the antipsychotic medication chlorpromazine. [ 1 ] [ 2 ] She discovered that the compound promazine had sedating properties despite not being an antihistamine like its precursor promethazine ...
A related concept to D2 potency is the concept of "chlorpromazine equivalence", which provides a measure of the relative effectiveness of antipsychotics. [ 13 ] [ 14 ] The measure specifies the amount (mass) in milligrams of a given drug that must be administered in order to achieve desired effects equivalent to those of 100 milligrams of ...
However, chlorpromazine proved to reduce the effects of psychosis in a more effective and specific manner than lobotomy, even though it was known to be capable of causing severe sedation. The underlying neurochemistry involved has since been studied in detail, and subsequent antipsychotic drugs have been developed by rational drug design.
3356 15558 Ensembl ENSG00000102468 ENSMUSG00000034997 UniProt P28223 P35363 RefSeq (mRNA) NM_001165947 NM_000621 NM_001378924 NM_172812 RefSeq (protein) NP_000612 NP_001159419 NP_001365853 NP_766400 Location (UCSC) Chr 13: 46.83 – 46.9 Mb n/a PubMed search Wikidata View/Edit Human View/Edit Mouse The 5-HT 2A receptor is a subtype of the 5-HT 2 receptor that belongs to the serotonin receptor ...
Jean Delay (14 November 1907, Bayonne – 29 May 1987, Paris) was a French psychiatrist, neurologist, writer, and a member of the Académie française (Chair 17).. His assistant Pierre Deniker conducted a test of chlorpromazine on the male mental ward where Delay worked, and the two published their findings (quickly, with what has been called academic gamesmanship) in 1952. [1]
Promazine (brand name Sparine among others), [2] is used as a short-term add-on treatment for psychomotor agitation. [3] [4] Its approved uses in people is limited, but is used as a tranquilizer in veterinary medicine. [3]